BRYON HIRSCHMAN: Open Payments
NPI 1194739912 · NORFOLK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,005 in 66 payments from 19 companies in 2025. Trend: 2023 $985 · 2024 $962 · 2025 $1,005
Food & beverage: $1,005
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $254 |
| PFIZER INC. | 11 | $138 |
| Otsuka America Pharmaceutical, Inc. | 5 | $91 |
| Novo Nordisk Inc | 5 | $86 |
| AstraZeneca Pharmaceuticals LP | 5 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Merck Sharp & Dohme LLC | 3 | $46 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Eisai Inc. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
Products named: REXULTI, UBRELVY, QULIPTA, PREVNAR 20, NURTEC ODT, Wegovy, CAPLYTA, HETLIOZ.
Industry payments across NE — which companies pay providers there.
